Synergistic antitumor effect of NVP-BEZ235 and CAPE on MDA-MB-231 breast cancer cells

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Samira TorkiMahdi Ghatrehsamani

Abstract

Triple negative breast cancer (TNBC) is the most lethal and aggressive kind of breast cancer. Studies with TNBC cells suggest that tumor environmental cytokines such as Transforming Growth Factor β1 (TGF-β1) have important roles in tumors fate. In the present study, we aimed to investigate, the effect of phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway dual inhibitor, NVP-BEZ235 and Caffeic acid phenyl ester (CAPE) on TNBC cell line (MDA-MB-231), stimulated with TGF-β1 for 14days in vitro. We found that TGF-β1 as a local tumor environmental cytokine plays important role in the progression and invasiveness of TNBC cells. NVP-BEZ235 inhibited the enhanced cell viability and CXCR4 expression induced by TGF-β1. In addition, the combined treatment of TNBC cell lines with CAPE and NVP-BEZ235 synergistically inhibited cell growth and reduced CXCR4 expression. Also, treatment of MDA-MB-231 cells with CAPE and NVP-BEZ235 led to decreasing the expression levels of p-FOXO3a in a time-dependent manner. Overall, these results suggest that tumor metastasis and progression in TNBC cells can be effectively reduced through the concurrent use of NVP-BEZ235 and CAPE. This could be of particular int...Continue Reading

References

Jan 31, 1998·The Journal of Clinical Investigation·M A SovakG E Sonenshein
Nov 14, 2002·Current Problems in Cancer·Harikrishna Nakshatri, Robert J Goulet
Nov 19, 2005·The Journal of Biological Chemistry·Martina I ReinholdMichael C Naski
Nov 4, 2006·Journal of the American Society of Nephrology : JASN·Mitsuo KatoRama Natarajan
Jan 22, 2008·Nature Cell Biology·Jer-Yen YangMien-Chie Hung
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jer-Yen Yang, Mien-Chie Hung
Jun 29, 2011·Biochimica Et Biophysica Acta·Guri TzivionGopalakrishnan Ramakrishnan
Jan 25, 2012·Gene Expression·Molly A TaylorWilliam P Schiemann
Jul 10, 2012·European Journal of Pharmacology·Heba H Mansour, Sameh S Tawfik
Apr 30, 2013·Cancer Letters·Kyung Hwa ChoHoi Young Lee
Feb 22, 2014·Advances in Bioscience and Biotechnology·Antonella ChiechiKhalid S Mohammad
Mar 13, 2014·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Martine CrosetPhilippe Clézardin
Jul 25, 2014·Therapeutic Advances in Medical Oncology·Elisavet Paplomata, Ruth O'Regan
Feb 28, 2015·Journal of Dietary Supplements·Seema Patel
Oct 9, 2015·Nature Medicine·Guido KroemerLaurence Zitvogel
Mar 24, 2016·Nutrition and Cancer·Tarek K MotawiSamia A Shouman
Oct 21, 2016·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Roswita H HamunyelaJohn M Akudugu

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.